The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process

por Khan, Aneal, Sirrs, Sandra M., Bichet, Daniel G., Morel, Chantal F., Tocoian, Adina, Lan, Lan, West, Michael L.
Publicado 2021

rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial

por Ley, David, Hallberg, Boubou, Hansen-Pupp, Ingrid, Dani, Carlo, Ramenghi, Luca A., Marlow, Neil, Beardsall, Kathryn, Bhatti, Faizah, Dunger, David, Higginson, Jason D., Mahaveer, Ajit, Mezu-Ndubuisi, Olachi J., Reynolds, Peter, Giannantonio, Carmen, van Weissenbruch, Mirjam, Barton, Norman, Tocoian, Adina, Hamdani, Mohamed, Jochim, Emily, Mangili, Alexandra, Chung, Jou-Ku, Turner, Mark A., Smith, Lois E. H., Hellström, Ann
Publicado 2018